Medical Elastomer Market

Report Code CH 6288
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Medical Elastomer Market by Type (Thermoset Elastomers; Thermoplastic Elastomers), Applications (Medical Tubing; Catheters; Syringes; Gloves; Medical & Infusion Bags and Implants), End-use Industry & Region - Global Forecast to 2029

Updated on : January 21, 2025

Medical Elastomer Market Overview

The global medical elastomer market was valued at USD 9.57 billion in 2024 and is projected to reach USD 14.27 billion by 2029, growing at 8.3% cagr from 2024 to 2029. The growing demand for medical devices in the healthcare industry such as surgical instruments and diagnostic tools which need components that are durable, flexible and biocompatible is driving demand for medical elastomers. These elastomers are widely used in various applications such as medical tubing, catheters, syringes, infusion bags and implants

Medical Elastomer Market

Attractive Opportunities in the Medical Elastomer Market

Asia Pacific

The market in the Asia Pacific is expected to witness high growth during the forecast period due to the factors driving market growth.

Market growth is attributed to the growing demand for medical devices in hospitals & clinics.

Rising aging population and rising prevalence of chronic diseases in Asia Pacific is driving the medical elastomer market in the region.

The Asia Pacific medical elastomer market is expected to be the fastest growing during the forecast period.

Stringent regulatory requirements is a challenge to the growth of this market.

Global Medical Elastomer Market Dynamics

DRIVER: Growing water demand for medical devices

The growing demand for medical devices is significantly driving the market for medical elastomer. The continuous expansion of the healthcare sector globally along with factors such as aging population, increasing prevalence of chronic diseases, and increased awareness concerning medical health, has increased the demand for advanced medical devices. With properties such as flexibility, durability, biocompatibility, resistance to heat, chemicals, and sterilization, the medical elastomers play a vital role in manufacturing of medical devices. Elastomers play a great role in critical healthcare applications, for example, in medical tubing, catheters, surgical gloves, seals, and implants-which are most important in the overall patient care. With an increasing use minimally invasive surgeries there has been an increase in demand for medical elastomer products in the form of flexible tubing and seals. There is also the push toward personalized medicine wherein devices are tailored to specific patient needs. This is coupled with the adoption and use of wearable health devices that utilize elastomers in comfortable and flexible components in the form of a wearable monitor or sensor. These factors when combined with expansion of healthcare services, technological advancements, and rising demands for patient specific solutions create a growing demand for medical devices as one of the major drivers of this medical elastomer market.

RESTRAINT: High production costs

High manufacturing costs are a major restraint for the medical elastomer market. The process of manufacturing medical elastomers is lengthy and incorporates several complexities and stringencies in quality checks to ensure it is biocompatible, durable, and resistant to sterilization. All these requirements result into higher production costs as compared to those of other materials that are used in medical devices. Some applications require advanced formulations, for instance, implants and surgical gloves, which require expensive additives and specialized processing, resulting in high costs. Material testing, certification, and validation also add to the cost, along with regulatory compliance and standards, such as FDA requirements. A further cost added to the final price of medical elastomers is the research and development investment in new elastomer formulations that can better meet changing healthcare requirements. High costs, inevitably, make medical elastomers quite inaccessible and unaffordable to patients in lower income developing countries with limited health care budgets. Such a restraint would result in market growth slowdown since increased manufacturers might experience problems with scale-up production or economies of scale, which in turn affects the overall supply chain and market penetration of medical elastomer products.

 

OPPORTUNITY: Growing healthcare investments in emerging economies

Investments in healthcare industry is currently growing in emerging economies which results into developing countries holding high potential for the medical elastomer market. The economies of developing countries in the Asia Pacific, South America, and Middle East regions are experiencing expanding health care infrastructures and services. Governments in these countries are investing heavily in health care infrastructure to meet their expanding populations' needs. Such investments create market demand for advanced medical devices and equipment that rely on elastomers for their parts such as tubing, catheters, seals, and implants. These factors are further supported by growing healthcare awareness and the increased availability of medical centers in the regions, which makes people more responsive to high-performance elastomers that provide safety for patients and reliability for devices. There is an increase in medical tourism in emerging markets, and thus the requirement for advanced medical devices made from elastomers. Antimicrobial and biocompatible elastomer materials are added to help developments in these regions identify new markets for manufacturers.

The medical elastomer industry will therefore witness significant growth by tapping into these fast-growing healthcare systems and similarly, by riding the ongoing modernization and quality health care created as a focus for emerging economies.

CHALLENGES: Stringent regulatory requirements

Stringent regulatory requirements are a significant challenge for the medical elastomer market. Elastomers have high usage in critical applications including implantable applications, medical tubing, and surgical instruments that require exceptional standards for both safety and biocompatibility. The approval processes by various regulatory authorities such as FDA, EMA, and others add to the cost and complexity factor in production by requiring manufacturers to high investment in intensive testing, certification, and compliance measures. Those doing extensive clinical trials, material validation, and full compliance with regulations such as ISO 10993 for biocompatibility testing. Constantly changing regulations, especially directives like the European Union's Medical Device Regulation (MDR), require manufacturers to continuously adapt to challenges like operational cost increases. This leads to demands on research and development to innovate with compliant materials, impacting the overall growth of the medical elastomer market. Non - compliance with these regulations may result in severe penalties, including product recalls or prohibition, causing both financial and reputational losses. Therefore, the complexity and expense of these norms undermine the growth and innovation of the medical elastomer market.

Global Medical Elastomer Market Ecosystem Analysis

The medical elastomer market ecosystem comprises raw material suppliers, manufacturers, distributors and end-use industries such as hospitals & clinics, pharmaceutical industry and medical device manufacturers. The raw materials for manufacturing medical elastomer primarily include polymers and specialty chemicals. Raw material suppliers supply necessary materials for the manufacturing of medical elastomers. These materials should strict regulatory standards for safety and biocompatibility. The raw materials are then processed by manufacturers into different forms of medical elastomers which have a wide range of applications such as syringes, catheters, and implants, among others. The distribution of the product is crucial for delivering of products to healthcare providers and manufacturers of medical devices. The end-use industries include hospitals, clinics, pharmaceutical industry and medical device manufacturers which use these elastomers for designing of innovative medical devices to address the rising healthcare needs by an aging population and increasing prevalence of chronic diseases.

Medical Elastomer Market
 

Thermoset elastomers to account for largest market share in the medical elastomer during forecast period

Thermoset elastomers account for the largest market share in the medical elastomer market due to their excellent durability, thermal stability and chemical resistance. These properties make thermoset elastomers suitable for applications that require reliability for long time along with consistent performance. Cross-linked structures of thermoset elastomers are cured by a chemical process which allows them to retain their strength and shape even when high temperatures or heat is applied. An important characteristic of thermoset elastomers is biocompatibility. They do not react harmfully with body tissues and fluids, which is required for certain medical devices, like orthopedic implants and cardiovascular devices. Growth in chronic diseases along with the medical device market has further fueled the demand for using thermosets in health care. With advancements in material science, thermoset elastomers can be customized to provide specific medical requirements, such as antimicrobial, better elasticity, or even comfort to the patient. Reliability and safety along with the flexibility of thermoset elastomers, places them among the most preferred elastomers for high-performance use in the medical field. These factors collectively result into thermoset elastomers accounting for the largest share in the medical elastomer market.

Medical tubing accounts largest market share of medical elastomer market by application during the forecast period, in terms of value.

Medical elastomer market accounts the largest market share for its application in medical tubing due to its vital role in various healthcare devices. It is widely used in applications like intravenous (IV) administration, catheters, dialysis and respiratory systems. These are vital for the care of patients. This growing demand for tubing materials with superior quality flexibility and durability is an added factor towards adoption of medical elastomer, which are biocompatible, resistant to chemicals, as well as easy to sterilize. Furthermore, the rise of the aging population and the prevalence of chronic diseases is raising the demand for medical tubing. The continued advancements in minimally invasive surgery and the growth of home healthcare solutions are also boosting demand for medical tubing in the medical elastomer market. Additionally, advances in elastomer materials, particularly antimicrobial and transparent variants, have positively impacted medical tubing performance by ensuring patient safety along with meeting stringent regulatory standards. In addition, globalization of healthcare infrastructure and improvements in design and materials are bound to help maintain the medical tubing as one of the key applications in the medical elastomer market.

North America to dominate medical elastomer market during forecast period

North America dominates the global market of medical elastomers due to its established healthcare infrastructure and large-scale investments in R&D besides a well-developed medical device industry. There are many large main medical device manufacturers operating within the region, thus increasing demand for high-performance elastomers in applications such as medical tubing, catheters, seals, and implants, among others. The US continuously requires sophisticated medical technologies, mainly because of an aging population, a vibrant healthcare network, and widespread medical practices. Strict regulatory standards by the FDA mandates use of material inputs that are viable and biocompatible for use in medical devices, thus further increasing the demand for high quality medical elastomers. The region also enjoys a powerful innovation quotient, with considerable investment in evolving next-generation elastomer materials that are capable of possessing superior properties such as resistance to microbial attack and flexibility. Adoption of minimally invasive surgical procedures, which necessitate advanced elastomer-based devices, is also driving the market. With increasing healthcare expenditure, strong technological advancements, and strong regulatory frameworks, North America continues to be a leading market for the medical elastomer industry. It has always set high standards regarding quality and performance worldwide.

HIGHEST CAGR MARKET IN 2023
ASIA PACIFIC FASTEST GROWING MARKET IN THE REGION
Medical Elastomer Market

Recent Developments of Medical Elastomer Market

  • In January 2024, BASF has inaugurated its largest single thermoplastic polyurethane production line globally at the Zhanjiang Verbund site in China.
  • In November 2022, Celanese Corporation had successfully completed the acquisition of a majority of Dupont’s Mobility & Materials (M&M) business.
  • In December 2023 Solvay has completed the spin-off of its specialties segment now operating as Syensqo.
  • In September 2023, Mitsubishi Chemical Group Corporation has announced the development of a plant-derived thermoplastic with a biomass content of up to 70%.

Key Market Players

KEY PLAYERS IN THE MEDICAL ELASTOMER MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Medical Elastomer Market?

Scope of the Report

Report Metric Details
Market size available for years 2020-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Kiloton; Value (USD Million)
Segments Type, Technology, Application and End-use Industry
Regions Asia Pacific, North America, Europe, Middle East & Africa, and South America

 

Key Questions Addressed by the Report

What is the current size of the global medical elastomer market?
The global medical elastomer market is estimated to reach USD 14.27 billion by 2029 from USD 9.57 billion in 2024, at a CAGR of 8.3% during the forecast period.
Who are the key players in the global medical elastomer market?
BASF (Germany), Dow (US), Celanese Corporation (US), Eastman Chemical Company (US), Syensqo (Belgium), Mitsubishi Chemical Group Corporation (Japan), Kuraray Co., Ltd. (Japan), ExxonMobil (US), Momentive Performance Materials (US), Envalior (Germany) and Zeon Corporation (Japan). are the key players in this market. They have the potential to broaden their product portfolio and compete with other key market players.
What are some of the drivers for the market growth?
Key drivers for the medical elastomer market include growing demand for medical devices and technological advancements in healthcare.
What are the different types of medical elastomers?
Thermoset elastomers and thermoplastic elastomers are widely used in this market.
What are the major end-use industries of medical elastomers?
Hositals & clinics and medical device manufacturers are main industries in this market.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Elastomer Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
26
RESEARCH METHODOLOGY
30
EXECUTIVE SUMMARY
40
PREMIUM INSIGHTS
44
MARKET OVERVIEW
47
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing demand for medical devices
    - Technological advancements in healthcare
    - Prevalence of chronic diseases
    RESTRAINTS
    - High production costs
    OPPORTUNITIES
    - Growing healthcare investments in emerging economies
    - Increasing use in minimally invasive devices
    CHALLENGES
    - Stringent regulatory requirements
  • 5.3 PORTER’S FIVE FORCES ANALYSIS
    THREAT FROM NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.5 MACROECONOMIC OUTLOOK
    GDP TRENDS AND FORECASTS
  • 5.6 IMPACT OF AI/GENAI
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 CASE STUDY ANALYSIS
    KENT ELASTOMERS HELPED IN TRANSITIONING TO NON-LATEX MEDICAL COMPONENTS
    COOPER UNIVERSITY HOSPITAL BOOSTS POLYPHENYLENE ETHER RESILIENCE WITH DENTEC SAFETY COMFORT-AIRNXMD
    TECNOFLON FKM AS HIGH-PERFORMANCE ALTERNATIVE TO SILICONE IN ORTHOPEDIC APPLICATIONS
  • 5.10 REGULATORY LANDSCAPE
    ENVIRONMENTAL REGULATIONS
    NORTH AMERICA
    ASIA PACIFIC
    EUROPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Extrusion technology
    - Compression molding
    COMPLEMENTARY TECHNOLOGIES
    - Co-extrusion technology
    ADJACENT TECHNOLOGIES
    - Additive manufacturing technology
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.13 TRADE ANALYSIS
    IMPORT SCENARIO (HS CODE 391000)
    EXPORT SCENARIO (HS CODE 391000)
    IMPORT SCENARIO (HS CODE 400270)
    EXPORT SCENARIO (HS CODE 400270)
  • 5.14 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.15 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION
    AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY APPLICATION
    AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY END-USE INDUSTRY
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 PATENT ANALYSIS
    INTRODUCTION
    LEGAL STATUS OF PATENTS
    JURISDICTION ANALYSIS
  • 5.18 LIST OF POTENTIAL CUSTOMERS
MEDICAL ELASTOMERS MARKET, BY TECHNOLOGY
83
  • 6.1 INTRODUCTION
  • 6.2 EXTRUSION
  • 6.3 INJECTION MOLDING
  • 6.4 COMPRESSION MOLDING
  • 6.5 OTHER TECHNOLOGIES
MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY
86
  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS & CLINICS
    RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 7.3 PHARMACEUTICAL
    CRUCIAL ROLE OF ELASTOMERS IN PACKAGING AND DRUG DELIVERY SYSTEMS TO PROPEL ADOPTION
  • 7.4 MEDICAL DEVICE MANUFACTURING
    RISING DEMAND FOR ADVANCED MEDICAL DEVICES TO SUPPORT MARKET GROWTH
  • 7.5 OTHER END-USE INDUSTRIES
MEDICAL ELASTOMERS MARKET, BY APPLICATION
91
  • 8.1 INTRODUCTION
  • 8.2 MEDICAL TUBING
    HIGH CONSUMPTION IN ADVANCING MEDICAL TUBING SOLUTIONS TO DRIVE MARKET
  • 8.3 CATHETERS
    VITAL ROLE IN PRODUCTION OF CATHETERS TO PROPEL GROWTH
  • 8.4 GLOVES
    INCREASING NEED FOR PERSONAL PROTECTIVE EQUIPMENT TO INCREASE DEMAND
  • 8.5 SYRINGES
    PRE-FILLED SYRINGES
    - Reduce risk of dosing errors—key factor driving adoption
    NON-PRE-FILLED SYRINGES
    - Increasing incidence of chronic diseases to propel adoption
    VIALS
    - Increasing need for safe and effective drug delivery systems to drive market
  • 8.6 MEDICAL & INFUSION BAGS
    RISE IN HOSPITAL-ACQUIRED INFECTIONS TO SUPPORT MARKET GROWTH
  • 8.7 IMPLANTS
    INCREASING PREVALENCE OF AGE-RELATED HEALTH CONDITIONS TO DRIVE MARKET
  • 8.8 OTHER APPLICATIONS
MEDICAL ELASTOMERS MARKET, BY TYPE
101
  • 9.1 INTRODUCTION
  • 9.2 THERMOSET ELASTOMERS
    SILICONE
    - Efficient alternative to latex products in medical and pharmaceutical applications
    - High temperature vulcanized
    - Liquid silicone rubber
    - Room temperature vulcanized
    ETHYLENE PROPYLENE DIENE MONOMER
    - Suitable for various medical applications—key factor supporting market growth
    OTHER THERMOSET ELASTOMERS
  • 9.3 THERMOPLASTIC ELASTOMERS
    THERMOPLASTIC POLYURETHANE
    - Provide efficiency in manufacturing complex designs using extrusion and molding techniques
    STYRENE BLOCK COPOLYMERS
    - Biostability of SBC increases utility in medical applications—key factor driving market growth
    OTHER THERMOPLASTIC ELASTOMERS
MEDICAL ELASTOMERS MARKET, BY REGION
108
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    US
    - Rising healthcare spending to drive market
    CANADA
    - Expanding healthcare system to support market growth
    MEXICO
    - Government initiatives and growth of healthcare sector to drive market
  • 10.3 ASIA PACIFIC
    CHINA
    - Growing aging population to drive market
    JAPAN
    - Increased focus on infection control and patient safety to propel market
    INDIA
    - Increasing investments in healthcare sector to drive market
    SOUTH KOREA
    - Rising demand for high quality medical devices to drive market
    INDONESIA
    - Rising incidence of chronic diseases to drive market
    REST OF ASIA PACIFIC
  • 10.4 EUROPE
    GERMANY
    - Increased investments in R&D to drive market
    UK
    - Rising geriatric population to support market growth
    FRANCE
    - Presence of significant medical device manufacturers to propel market
    ITALY
    - Rising demand for medical devices from public hospitals to increase demand
    SPAIN
    - Increasing investments in healthcare infrastructure to propel market
    REST OF EUROPE
  • 10.5 MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Saudi Arabia
    - Rest of GCC countries
    SOUTH AFRICA
    - Outbreak of contagious diseases to drive market
    REST OF MIDDLE EAST & AFRICA
  • 10.6 SOUTH AMERICA
    BRAZIL
    - Largest market for medical elastomers in South America
    ARGENTINA
    - Growing demand for medical devices to drive market
    REST OF SOUTH AMERICA
COMPETITIVE LANDSCAPE
244
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019–2024
  • 11.3 REVENUE ANALYSIS, 2021–2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
    NORTH AMERICA: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    EUROPE: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    ASIA PACIFIC: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    DOW
    EXXON MOBIL CORPORATION
    CELANESE CORPORATION
    BASF
    WACKER CHEMIE AG
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
    MEDICAL ELASTOMERS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
    ELASTOLLAN
    ENGAGE 8480K HEALTH+
    HYTREL
    ECDEL
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Overall company footprint
    - Region footprint
    - Technology footprint
    - Type Footprint
    - Application footprint
    - Industry footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of startups/SMEs
    - Competitive benchmarking of startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
271
  • 12.1 KEY PLAYERS
    DOW
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    EXXON MOBIL CORPORATION
    - Business overview
    - Products offered
    - MnM view
    CELANESE CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BASF
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    WACKER CHEMIE AG
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    EASTMAN CHEMICAL COMPANY
    - Business overview
    - Products offered
    - MnM view
    SYENSQO
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    KURARAY CO., LTD
    - Business overview
    - Products offered
    - MnM view
    MITSUBISHI CHEMICAL GROUP CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MOMENTIVE PERFORMANCE MATERIALS
    - Business overview
    - Products offered
    - MnM view
    ENVALIOR
    - Business overview
    - Products offered
    ZEON CORPORATION
    - Business overview
    - Products offered
    THE LUBRIZOL CORPORATION
    - Business overview
    - Products offered
    - MnM view
  • 12.2 OTHER PLAYERS
    KRATON CORPORATION
    FOSTER CORPORATION
    BIOMERICS
    RTP COMPANY
    ROMAR ENGINEERING
    THE RUBBER GROUP
    KENT ELASTOMER PRODUCTS
    RAUMEDIC AG
    THE HYGENIC COMPANY, LLC
    HEXAPOL AB
    TEKNI-PLEX, INC
    TRINSEO
    TRELLEBORG AB
    SAINT-GOBAIN
APPENDIX
326
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 US: CONSUMER MEDICAL DEVICES SALES, 2021–2023 (USD MILLION)
  • TABLE 2 MEDICAL ELASTOMERS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP-THREE END–USE INDUSTRIES
  • TABLE 4 KEY BUYING CRITERIA FOR TOP-THREE END-USE INDUSTRIES
  • TABLE 5 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019–2023
  • TABLE 6 GDP ANNUAL PERCENTAGE CHANGE AND PROJECTION OF KEY COUNTRIES, 2024–2029
  • TABLE 7 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019–2022
  • TABLE 8 MEDICAL ELASTOMERS MARKET: ROLE OF PLAYERS IN ECOSYSTEM
  • TABLE 9 MEDICAL ELASTOMERS MARKET: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 IMPORT DATA FOR HS CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 11 EXPORT DATA FOR HS CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 12 IMPORT DATA FOR HS CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR HS CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 14 MEDICAL ELASTOMERS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 15 LIST OF PATENTS, 2024
  • TABLE 16 LIST OF POTENTIAL CUSTOMERS
  • TABLE 17 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON)
  • TABLE 18 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON)
  • TABLE 19 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)
  • TABLE 20 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)
  • TABLE 21 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 22 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 23 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 24 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 25 MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON)
  • TABLE 26 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 27 MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 28 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 29 MEDICAL ELASTOMERS MARKET, BY REGION, 2021–2023 (KILOTON)
  • TABLE 30 MEDICAL ELASTOMERS MARKET, BY REGION, 2024–2029 (KILOTON)
  • TABLE 31 MEDICAL ELASTOMERS MARKET, BY REGION, 2021–2023 (USD MILLION)
  • TABLE 32 MEDICAL ELASTOMERS MARKET, BY REGION, 2024–2029 (USD MILLION)
  • TABLE 33 NORTH AMERICA: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023
  • TABLE 34 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (KILOTON)
  • TABLE 35 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 36 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 37 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 38 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON)
  • TABLE 39 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 40 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 41 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 42 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 43 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 44 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 45 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON)
  • TABLE 47 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON)
  • TABLE 48 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)
  • TABLE 49 NORTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)
  • TABLE 50 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 51 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 52 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 53 US: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 54 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 55 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 56 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 57 CANADA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 58 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 59 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 60 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 61 MEXICO: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023
  • TABLE 63 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (KILOTON)
  • TABLE 64 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 65 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON)
  • TABLE 68 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 69 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 72 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 73 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON)
  • TABLE 76 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON)
  • TABLE 77 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)
  • TABLE 79 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 80 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 81 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 82 CHINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 83 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 84 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 85 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 86 JAPAN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 87 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 88 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 89 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 90 INDIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 91 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 92 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 93 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 94 SOUTH KOREA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 95 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 96 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 97 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 98 INDONESIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 99 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 100 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 101 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 102 REST OF ASIA PACIFIC: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 103 EUROPE: MARKET SHARES OF DIFFERENT TYPES OF MEDICAL ELASTOMERS, BY APPLICATION, 2023
  • TABLE 104 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (KILOTON)
  • TABLE 105 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 106 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 107 EUROPE: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 108 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON)
  • TABLE 109 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 110 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 111 EUROPE: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 112 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 113 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 114 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 115 EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 116 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON)
  • TABLE 117 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON)
  • TABLE 118 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)
  • TABLE 119 EUROPE: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)
  • TABLE 120 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 121 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 122 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 123 GERMANY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 124 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 125 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 126 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 127 UK: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 128 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 129 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 130 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 131 FRANCE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 132 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 133 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 134 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 135 ITALY: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 136 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 137 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 138 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 139 SPAIN: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 140 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 141 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 142 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 143 REST OF EUROPE: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 144 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (KILOTON)
  • TABLE 145 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 146 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON)
  • TABLE 149 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 150 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 153 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 154 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 156 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON)
  • TABLE 157 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON)
  • TABLE 158 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)
  • TABLE 159 MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)
  • TABLE 160 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 161 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 162 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 163 SAUDI ARABIA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 164 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 165 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 166 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 167 REST OF GCC COUNTRIES: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 168 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 169 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 170 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 171 SOUTH AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 172 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 173 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 174 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 175 REST OF MIDDLE EAST & AFRICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 176 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (KILOTON)
  • TABLE 177 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (KILOTON)
  • TABLE 178 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 179 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 180 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (KILOTON)
  • TABLE 181 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (KILOTON)
  • TABLE 182 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 183 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 184 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 185 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 186 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 187 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 188 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (KILOTON)
  • TABLE 189 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (KILOTON)
  • TABLE 190 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2021–2023 (USD MILLION)
  • TABLE 191 SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024–2029 (USD MILLION)
  • TABLE 192 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 193 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 194 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 195 BRAZIL: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 196 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 197 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 198 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 199 ARGENTINA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 200 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (KILOTON)
  • TABLE 201 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (KILOTON)
  • TABLE 202 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 203 REST OF SOUTH AMERICA: MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 204 MEDICAL ELASTOMERS MARKET: DEGREE OF COMPETITION
  • TABLE 205 NORTH AMERICA: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023
  • TABLE 206 NORTH AMERICA: MARKET SHARE ANALYSIS, BY CATHETER, 2023
  • TABLE 207 NORTH AMERICA: MARKET SHARE ANALYSIS, BY SYRINGE, 2023
  • TABLE 208 EUROPE: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023
  • TABLE 209 EUROPE: MARKET SHARE ANALYSIS, BY CATHETER, 2023
  • TABLE 210 EUROPE: MARKET SHARE ANALYSIS, BY SYRINGE, 2023
  • TABLE 211 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY MEDICAL TUBING, 2023
  • TABLE 212 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY CATHETER, 2023
  • TABLE 213 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY SYRINGE, 2023
  • TABLE 214 MEDICAL ELASTOMERS MARKET: REGION FOOTPRINT
  • TABLE 215 MEDICAL ELASTOMERS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 216 MEDICAL ELASTOMERS MARKET: TYPE FOOTPRINT
  • TABLE 217 MEDICAL ELASTOMERS MARKET: APPLICATION FOOTPRINT
  • TABLE 218 MEDICAL ELASTOMERS MARKET: INDUSTRY FOOTPRINT
  • TABLE 219 MEDICAL ELASTOMERS MARKET: KEY STARTUPS/SMES
  • TABLE 220 MEDICAL ELASTOMERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 221 MEDICAL ELASTOMERS MARKET: PRODUCT LAUNCHES, JANUARY 2019–NOVEMBER 2024
  • TABLE 222 MEDICAL ELASTOMERS MARKET: DEALS, JANUARY 2019–NOVEMBER 2024
  • TABLE 223 MEDICAL ELASTOMERS MARKET: EXPANSIONS, JANUARY 2019–NOVEMBER 2024
  • TABLE 224 MEDICAL ELASTOMERS MARKET: OTHER DEVELOPMENTS, JANUARY 2019– NOVEMBER 2024
  • TABLE 225 DOW: COMPANY OVERVIEW
  • TABLE 226 DOW.: PRODUCTS OFFERED
  • TABLE 227 DOW: OTHER DEVELOPMENTS, JANUARY 2019–NOVEMBER 2024
  • TABLE 228 EXXON MOBIL CORPORATION: COMPANY OVERVIEW
  • TABLE 229 EXXON MOBIL CORPORATION: PRODUCT OFFERINGS
  • TABLE 230 CELANESE CORPORATION: COMPANY OVERVIEW
  • TABLE 231 CELANESE CORPORATION: PRODUCTS OFFERED
  • TABLE 232 CELANESE CORPORATION: DEALS, JANUARY 2019–NOVEMBER 2024
  • TABLE 233 BASF: COMPANY OVERVIEW
  • TABLE 234 BASF: PRODUCTS OFFERED
  • TABLE 235 BASF: EXPANSIONS, JANUARY 2019–NOVEMBER 2024
  • TABLE 236 WACKER CHEMIE AG: COMPANY OVERVIEW
  • TABLE 237 WACKER CHEMIE AG: PRODUCTS OFFERED
  • TABLE 238 WACKER CHEMIE AG: PRODUCT LAUNCHES, JANUARY 2019–NOVEMBER 2024
  • TABLE 239 WACKER CHEMIE AG: EXPANSIONS, JANUARY 2019–NOVEMBER 2024
  • TABLE 240 EASTMAN CHEMICAL COMPANY: COMPANY OVERVIEW
  • TABLE 241 EASTMAN CHEMICAL COMPANY: PRODUCTS OFFERED
  • TABLE 242 SYENSQO: COMPANY OVERVIEW
  • TABLE 243 SYENSQO: PRODUCTS OFFERED
  • TABLE 244 SYENSQO: OTHER DEVELOPMENTS, JANUARY 2019–NOVEMBER 2024
  • TABLE 245 KURARAY CO., LTD: COMPANY OVERVIEW
  • TABLE 246 KURARAY CO., LTD: PRODUCT OFFERINGS
  • TABLE 247 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY OVERVIEW
  • TABLE 248 MITSUBISHI CHEMICAL GROUP CORPORATION: PRODUCTS OFFERED
  • TABLE 249 MITSUBISHI CHEMICAL GROUP CORPORATION: OTHER DEVELOPMENTS, JANUARY 2019–NOVEMBER 2024
  • TABLE 250 MITSUBISHI CHEMICAL GROUP CORPORATION: DEALS, JANUARY 2019– NOVEMBER 2024
  • TABLE 251 MOMENTIVE PERFORMANCE MATERIALS: COMPANY OVERVIEW
  • TABLE 252 MOMENTIVE PERFORMANCE MATERIALS: PRODUCTS OFFERED
  • TABLE 253 ENVALIOR: COMPANY OVERVIEW
  • TABLE 254 ENVALIOR: PRODUCTS OFFERED
  • TABLE 255 ZEON CORPORATION: COMPANY OVERVIEW
  • TABLE 256 ZEON CORPORATION: PRODUCTS OFFERED
  • TABLE 257 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW
  • TABLE 258 THE LUBRIZOL CORPORATION: PRODUCTS OFFERED
  • TABLE 259 KRATON CORPORATION: COMPANY OVERVIEW
  • TABLE 260 FOSTER CORPORATION: COMPANY OVERVIEW
  • TABLE 261 BIOMERICS: COMPANY OVERVIEW
  • TABLE 262 RTP COMPANY: COMPANY OVERVIEW
  • TABLE 263 ROMAR ENGINEERING: COMPANY OVERVIEW
  • TABLE 264 THE RUBBER GROUP: COMPANY OVERVIEW
  • TABLE 265 KENT ELASTOMER PRODUCTS: COMPANY OVERVIEW
  • TABLE 266 RAUMEDIC AG: COMPANY OVERVIEW
  • TABLE 267 THE HYGENIC COMPANY, LLC: COMPANY OVERVIEW
  • TABLE 268 HEXAPOL AB: COMPANY OVERVIEW
  • TABLE 269 TEKNI-PLEX, INC: COMPANY OVERVIEW
  • TABLE 270 TRINSEO: COMPANY OVERVIEW
  • TABLE 271 TRELLEBORG AB: COMPANY OVERVIEW
  • TABLE 272 SAINT-GOBAIN: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MEDICAL ELASTOMERS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 MEDICAL ELASTOMERS MARKET: RESEARCH DESIGN
  • FIGURE 3 MEDICAL ELASTOMERS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4 MEDICAL ELASTOMERS MARKET: TOP-DOWN APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL ELASTOMERS MARKET (TOP-DOWN APPROACH)
  • FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS
  • FIGURE 7 MEDICAL ELASTOMERS MARKET: DATA TRIANGULATION
  • FIGURE 8 THERMOSET ELASTOMERS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 9 MEDICAL TUBING APPLICATION TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 10 HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD
  • FIGURE 12 GROWING DEMAND FOR MEDICAL DEVICES FROM HEALTHCARE SECTOR TO DRIVE MARKET
  • FIGURE 13 THERMOPLASTIC ELASTOMERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 14 IMPLANTS SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 15 HOSPITALS & CLINICS TO BE LARGEST END-USE INDUSTRY FOR MEDICAL ELASTOMERS
  • FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL ELASTOMERS MARKET
  • FIGURE 18 MEDICAL ELASTOMERS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END-USE INDUSTRIES
  • FIGURE 20 KEY BUYING CRITERIA FOR TOP-THREE END-USE INDUSTRIES
  • FIGURE 21 MEDICAL ELASTOMERS MARKET: ECOSYSTEM
  • FIGURE 22 MEDICAL ELASTOMERS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 23 IMPORT DATA FOR HS-CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY 2019–2023 (USD THOUSAND)
  • FIGURE 24 EXPORT DATA FOR HS-CODE 391000-COMPLIANT PRODUCTS, BY COUNTRY 2019–2023 (USD THOUSAND)
  • FIGURE 25 IMPORT DATA FOR HS-CODE 400270-COMPLIANT PRODUCTS, BY COUNTRY 2019–2023 (USD THOUSAND)
  • FIGURE 26 EXPORT DATA FOR HS CODE 400270–COMPLIANT PRODUCTS, BY COUNTRY 2019–2023 (USD THOUSAND)
  • FIGURE 27 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION (USD/KG), 2021–2023
  • FIGURE 28 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY APPLICATION (USD/KG), 2021–2023
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY END-USE INDUSTRY (USD/KG), 2021–2023
  • FIGURE 30 INVESTMENT AND FUNDING SCENARIO, 2021–2023 (USD MILLION)
  • FIGURE 31 PATENTS APPLIED AND GRANTED, 2014–2023
  • FIGURE 32 LEGAL STATUS OF PATENTS (2013–2024)
  • FIGURE 33 TOP JURISDICTIONS
  • FIGURE 34 HOSPITALS & CLINICS SEGMENT TO BE LARGEST END-USE INDUSTRY DURING FORECAST PERIOD
  • FIGURE 35 MEDICAL TUBING TO BE LARGEST APPLICATION SEGMENT DURING FORECAST PERIOD
  • FIGURE 36 THERMOSET ELASTOMERS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 37 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 38 NORTH AMERICA: MEDICAL ELASTOMERS MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: MEDICAL ELASTOMERS MARKET SNAPSHOT
  • FIGURE 40 EUROPE: MEDICAL ELASTOMERS MARKET SNAPSHOT
  • FIGURE 41 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL ELASTOMERS MARKET BETWEEN JANUARY 2019 AND NOVEMBER 2024
  • FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL ELASTOMERS MARKET, 2021–2023
  • FIGURE 43 MEDICAL ELASTOMERS MARKET SHARE OF KEY PLAYERS, 2023
  • FIGURE 44 VALUATION OF LEADING COMPANIES IN MEDICAL ELASTOMERS MARKET, 2023
  • FIGURE 45 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL ELASTOMERS MARKET, 2023
  • FIGURE 46 MEDICAL ELASTOMERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 47 MEDICAL ELASTOMERS MARKET: OVERALL COMPANY FOOTPRINT
  • FIGURE 48 MEDICAL ELASTOMERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 49 DOW: COMPANY SNAPSHOT
  • FIGURE 50 EXXON MOBIL CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 CELANESE CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52 BASF: COMPANY SNAPSHOT
  • FIGURE 53 WACKER CHEMIE AG: COMPANY SNAPSHOT
  • FIGURE 54 EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
  • FIGURE 55 SYENSQO: COMPANY SNAPSHOT
  • FIGURE 56 KURARAY CO., LTD: COMPANY SNAPSHOT
  • FIGURE 57 MITSUBISHI CHEMICAL GROUP CORPORATION: COMPANY SNAPSHOT
  • FIGURE 58 ZEON CORPORATION: COMPANY SNAPSHOT

 

The study involved four major activities in estimating the market size of the medical elastomer market. Exhaustive secondary research was done to collect information on the market, the peer market, and the grandparent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources have been referred to for identifying and collecting information for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, certified publications, trade directories, articles from recognized authors, gold standard and silver standard websites, and databases. Secondary research has been used to obtain key information about the value chain of the industry, monetary chain of the market, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The medical elastomer market comprises several stakeholders in the value chain, which include manufacturers, and end users. Various primary sources from the supply and demand sides of the medical elastomer market have been interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include key opinion leaders in industrial sectors. The primary sources from the supply side include manufacturers, associations, and institutions involved in the medical elastomer industry. Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, material, end-use industry, and region. Stakeholders from the demand side, such as CIOs, CTOs, and CSOs were interviewed to understand the buyer’s perspective on the suppliers, products, component providers, and their current usage of medical elastomer and outlook of their business, which will affect the overall market.

The breakdown of profiles of the primary interviewees is illustrated in the figure below:

Medical Elastomer Market

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022 available in the public domain, product portfolios, and geographical presence.

Other designations include consultants and sales, marketing, and procurement managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches have been used to estimate and validate the size of the medical elastomer market.

  • The key players in the industry have been identified through extensive secondary research.
  • The supply chain of the industry has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research includes the study of reports, reviews, and newsletters of the key market players, along with extensive interviews for opinions with leaders such as directors and marketing executives.
Medical Elastomer Market

Data Triangulation

After arriving at the total market size from the estimation process, the overall market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and sub-segments, the data triangulation and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size has been validated by using both the top-down and bottom-up approaches and primary interviews. Hence, for every data segment, there have been three sources—top-down approach, bottom-up approach, and expert interviews. The data was assumed correct when the values arrived from the three sources matched.

Market Definition

Elastomers are advanced polymers which possess both elastic and viscous properties. Due to the features of these materials, which include biocompatibility and flexibility and durability, they are widely used in the medical field. They are often found in a range of medical devices and applications, including, syringes, tubes, implants, and drug delivery devices. Medical elastomers may be placed in two categories: thermoplastic elastomers (TPEs) and thermoset elastomers. TPEs are considered highly important in fabricating complex parts of medical devices due to their flexibility which reduces the operation cost for production.

Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department
  • Manufacturers
  • Raw Material Suppliers

Report Objectives

  • To define, describe, and forecast the size of the medical elastomer market, in terms of value and volume.
  • To provide detailed information regarding the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
  • To estimate and forecast the market size based on type, technology, application, end-use industry, and region.
  • To forecast the size of the market with respect to major regions, namely, Europe, North America, Asia Pacific, Middle East & Africa, and South America, along with their key countries
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and their contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape of market leaders.
  • To track and analyze recent developments such as expansions, new product launches, partnerships & agreements, and acquisitions in the market.
  • To strategically profile key market players and comprehensively analyze their core competencies.

Previous Versions of this Report

Medical Elastomers Market by Type (Thermoset and Thermoplastic), Application (Medical Tubes, Catheters, Syringes, Gloves, Medical Bags, and Implants), and Region (North America, Europe, APAC, MEA, and South America) Global Forecast to 2022

Report Code CH 6288
Published in May, 2018, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Medical Elastomer Market

DMCA.com Protection Status